FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023233861> ?p ?o ?g. }

• W2023233861 endingPage "624" @default.
• W2023233861 startingPage "616" @default.
• W2023233861 abstract "Anti-coagulation with heparin is often used after left ventricular assist device implantation as a transition to long-term warfarin therapy. We retrospectively evaluated the effects of heparin use on thromboembolic and bleeding complications after implantation of the HeartMate II left ventricular assist device (LVAD).LVAD patients (n = 418) implanted as a bridge to transplant were divided into three groups: Group A patients (therapeutic, n = 118) received heparin and had a partial thromboplastin time (PTT) of >50 seconds on two or more occasions; Group B patients (sub-therapeutic, n = 178) had at least one PTT value in the range of 40 to 55 seconds; and Group C patients (no heparin, n = 122) had no PTT values >40 seconds. All patients were transitioned to warfarin and aspirin therapy. The following adverse events were evaluated: ischemic stroke; hemorrhagic stroke; pump thrombosis; bleeding requiring surgery; and bleeding requiring > or = 2 units of packed red blood cells in 24 hours.There was no difference in the percentages of patients with ischemic (5%, 4%, 3%) or hemorrhagic (3%, 3%, 5%) strokes or pump thrombosis (3%, 2%, 2%) after post-operative day (POD) 3 among Groups A, B and C, respectively. From PODs 3 to 30, the percentage of patients requiring transfusion for bleeding was significantly lower for Group C (18%) than for Groups A (32%) and B (26%) (p = 0.04); differences after 30 days were not significant. Multivariate analysis revealed that post-operative heparin use, low post-operative platelet count and low baseline hematocrit value were independent risk factors for bleeding events between PODs 3 and 30.In patients receiving the HeartMate II LVAD who were directly transitioned to warfarin and aspirin therapy without intravenous heparin there was no short-term increase in risk of thrombotic or thromboembolic events, and bleeding requiring transfusion was significantly reduced. Additional long-term follow-up is needed to evaluate possible late effects." @default.
• W2023233861 created "2016-06-24" @default.
• W2023233861 creator A5007048499 @default.
• W2023233861 creator A5007806159 @default.
• W2023233861 creator A5020106529 @default.
• W2023233861 creator A5030829598 @default.
• W2023233861 creator A5054034179 @default.
• W2023233861 creator A5068594160 @default.
• W2023233861 creator A5077905888 @default.
• W2023233861 creator A5080446143 @default.
• W2023233861 creator A5086114384 @default.
• W2023233861 creator A5089505905 @default.
• W2023233861 date "2010-06-01" @default.
• W2023233861 modified "2023-10-16" @default.
• W2023233861 title "Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy" @default.
• W2023233861 cites W1984169032 @default.
• W2023233861 cites W1985296787 @default.
• W2023233861 cites W1997780004 @default.
• W2023233861 cites W2010798210 @default.
• W2023233861 cites W2013993096 @default.
• W2023233861 cites W2028744469 @default.
• W2023233861 cites W2041092771 @default.
• W2023233861 cites W2079613552 @default.
• W2023233861 cites W2106552212 @default.
• W2023233861 cites W2109269649 @default.
• W2023233861 cites W2113301774 @default.
• W2023233861 cites W2113513543 @default.
• W2023233861 cites W2150046760 @default.
• W2023233861 cites W2154358434 @default.
• W2023233861 cites W2165719156 @default.
• W2023233861 cites W2169138421 @default.
• W2023233861 doi "https://doi.org/10.1016/j.healun.2010.02.003" @default.
• W2023233861 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20400335" @default.
• W2023233861 hasPublicationYear "2010" @default.
• W2023233861 type Work @default.
• W2023233861 sameAs 2023233861 @default.
• W2023233861 citedByCount "134" @default.
• W2023233861 countsByYear W20232338612012 @default.
• W2023233861 countsByYear W20232338612013 @default.
• W2023233861 countsByYear W20232338612014 @default.
• W2023233861 countsByYear W20232338612015 @default.
• W2023233861 countsByYear W20232338612016 @default.
• W2023233861 countsByYear W20232338612017 @default.
• W2023233861 countsByYear W20232338612018 @default.
• W2023233861 countsByYear W20232338612019 @default.
• W2023233861 countsByYear W20232338612020 @default.
• W2023233861 countsByYear W20232338612021 @default.
• W2023233861 countsByYear W20232338612023 @default.
• W2023233861 crossrefType "journal-article" @default.
• W2023233861 hasAuthorship W2023233861A5007048499 @default.
• W2023233861 hasAuthorship W2023233861A5007806159 @default.
• W2023233861 hasAuthorship W2023233861A5020106529 @default.
• W2023233861 hasAuthorship W2023233861A5030829598 @default.
• W2023233861 hasAuthorship W2023233861A5054034179 @default.
• W2023233861 hasAuthorship W2023233861A5068594160 @default.
• W2023233861 hasAuthorship W2023233861A5077905888 @default.
• W2023233861 hasAuthorship W2023233861A5080446143 @default.
• W2023233861 hasAuthorship W2023233861A5086114384 @default.
• W2023233861 hasAuthorship W2023233861A5089505905 @default.
• W2023233861 hasBestOaLocation W20232338611 @default.
• W2023233861 hasConcept C126322002 @default.
• W2023233861 hasConcept C127413603 @default.
• W2023233861 hasConcept C141071460 @default.
• W2023233861 hasConcept C164705383 @default.
• W2023233861 hasConcept C197934379 @default.
• W2023233861 hasConcept C2776301958 @default.
• W2023233861 hasConcept C2777557582 @default.
• W2023233861 hasConcept C2777628954 @default.
• W2023233861 hasConcept C2778198053 @default.
• W2023233861 hasConcept C2778261982 @default.
• W2023233861 hasConcept C2778382381 @default.
• W2023233861 hasConcept C2778774980 @default.
• W2023233861 hasConcept C2779161974 @default.
• W2023233861 hasConcept C2780434524 @default.
• W2023233861 hasConcept C2780645631 @default.
• W2023233861 hasConcept C2780868729 @default.
• W2023233861 hasConcept C2780959883 @default.
• W2023233861 hasConcept C42219234 @default.
• W2023233861 hasConcept C71924100 @default.
• W2023233861 hasConcept C78519656 @default.
• W2023233861 hasConceptScore W2023233861C126322002 @default.
• W2023233861 hasConceptScore W2023233861C127413603 @default.
• W2023233861 hasConceptScore W2023233861C141071460 @default.
• W2023233861 hasConceptScore W2023233861C164705383 @default.
• W2023233861 hasConceptScore W2023233861C197934379 @default.
• W2023233861 hasConceptScore W2023233861C2776301958 @default.
• W2023233861 hasConceptScore W2023233861C2777557582 @default.
• W2023233861 hasConceptScore W2023233861C2777628954 @default.
• W2023233861 hasConceptScore W2023233861C2778198053 @default.
• W2023233861 hasConceptScore W2023233861C2778261982 @default.
• W2023233861 hasConceptScore W2023233861C2778382381 @default.
• W2023233861 hasConceptScore W2023233861C2778774980 @default.
• W2023233861 hasConceptScore W2023233861C2779161974 @default.
• W2023233861 hasConceptScore W2023233861C2780434524 @default.
• W2023233861 hasConceptScore W2023233861C2780645631 @default.
• W2023233861 hasConceptScore W2023233861C2780868729 @default.
• W2023233861 hasConceptScore W2023233861C2780959883 @default.
• W2023233861 hasConceptScore W2023233861C42219234 @default.

• next